Cargando…

Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi

BACKGROUND: Kato-Katz examination of stool smears is the field-standard method for detecting Schistosoma mansoni infection. However, Kato-Katz misses many active infections, especially of light intensity. Point-of-care circulating cathodic antigen (CCA) is an alternative field diagnostic that is mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Clements, Michelle N., Corstjens, Paul L. A. M., Binder, Sue, Campbell, Carl H., de Dood, Claudia J., Fenwick, Alan, Harrison, Wendy, Kayugi, Donatien, King, Charles H., Kornelis, Dieuwke, Ndayishimiye, Onesime, Ortu, Giuseppina, Lamine, Mariama Sani, Zivieri, Antonio, Colley, Daniel G., van Dam, Govert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824563/
https://www.ncbi.nlm.nih.gov/pubmed/29475457
http://dx.doi.org/10.1186/s13071-018-2700-4
_version_ 1783302051918249984
author Clements, Michelle N.
Corstjens, Paul L. A. M.
Binder, Sue
Campbell, Carl H.
de Dood, Claudia J.
Fenwick, Alan
Harrison, Wendy
Kayugi, Donatien
King, Charles H.
Kornelis, Dieuwke
Ndayishimiye, Onesime
Ortu, Giuseppina
Lamine, Mariama Sani
Zivieri, Antonio
Colley, Daniel G.
van Dam, Govert J.
author_facet Clements, Michelle N.
Corstjens, Paul L. A. M.
Binder, Sue
Campbell, Carl H.
de Dood, Claudia J.
Fenwick, Alan
Harrison, Wendy
Kayugi, Donatien
King, Charles H.
Kornelis, Dieuwke
Ndayishimiye, Onesime
Ortu, Giuseppina
Lamine, Mariama Sani
Zivieri, Antonio
Colley, Daniel G.
van Dam, Govert J.
author_sort Clements, Michelle N.
collection PubMed
description BACKGROUND: Kato-Katz examination of stool smears is the field-standard method for detecting Schistosoma mansoni infection. However, Kato-Katz misses many active infections, especially of light intensity. Point-of-care circulating cathodic antigen (CCA) is an alternative field diagnostic that is more sensitive than Kato-Katz when intensity is low, but interpretation of CCA-trace results is unclear. To evaluate trace results, we tested urine and stool specimens from 398 pupils from eight schools in Burundi using four approaches: two in Burundi and two in a laboratory in Leiden, the Netherlands. In Burundi, we used Kato-Katz and point-of-care CCA (CCAB). In Leiden, we repeated the CCA (CCAL) and also used Up-Converting Phosphor Circulating Anodic Antigen (CAA). METHODS: We applied Bayesian latent class analyses (LCA), first considering CCA traces as negative and then as positive. We used the LCA output to estimate validity of the prevalence estimates of each test in comparison to the population-level infection prevalence and estimated the proportion of trace results that were likely true positives. RESULTS: Kato-Katz yielded the lowest prevalence (6.8%), and CCAB with trace considered positive yielded the highest (53.5%). There were many more trace results recorded by CCA in Burundi (32.4%) than in Leiden (2.3%). Estimated prevalence with CAA was 46.5%. LCA indicated that Kato-Katz had the lowest sensitivity: 15.9% [Bayesian Credible Interval (BCI): 9.2–23.5%] with CCA-trace considered negative and 15.0% with trace as positive (BCI: 9.6–21.4%), implying that Kato-Katz missed approximately 85% of infections. CCAB underestimated disease prevalence when trace was considered negative and overestimated disease prevalence when trace was considered positive, by approximately 12 percentage points each way, and CAA overestimated prevalence in both models. Our results suggest that approximately 52.2% (BCI: 37.8–5.8%) of the CCAB trace readings were true infections. CONCLUSIONS: Whether measured in the laboratory or the field, CCA outperformed Kato-Katz at the low infection intensities in Burundi. CCA with trace as negative likely missed many infections, whereas CCA with trace as positive overestimated prevalence. In the absence of a field-friendly gold standard diagnostic, the use of a variety of diagnostics with differing properties will become increasingly important as programs move towards elimination of schistosomiasis. It is clear that CCA is a valuable tool for the detection and mapping of S. mansoni infection in the field and CAA may be a valuable field tool in the future. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-018-2700-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5824563
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58245632018-02-26 Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi Clements, Michelle N. Corstjens, Paul L. A. M. Binder, Sue Campbell, Carl H. de Dood, Claudia J. Fenwick, Alan Harrison, Wendy Kayugi, Donatien King, Charles H. Kornelis, Dieuwke Ndayishimiye, Onesime Ortu, Giuseppina Lamine, Mariama Sani Zivieri, Antonio Colley, Daniel G. van Dam, Govert J. Parasit Vectors Research BACKGROUND: Kato-Katz examination of stool smears is the field-standard method for detecting Schistosoma mansoni infection. However, Kato-Katz misses many active infections, especially of light intensity. Point-of-care circulating cathodic antigen (CCA) is an alternative field diagnostic that is more sensitive than Kato-Katz when intensity is low, but interpretation of CCA-trace results is unclear. To evaluate trace results, we tested urine and stool specimens from 398 pupils from eight schools in Burundi using four approaches: two in Burundi and two in a laboratory in Leiden, the Netherlands. In Burundi, we used Kato-Katz and point-of-care CCA (CCAB). In Leiden, we repeated the CCA (CCAL) and also used Up-Converting Phosphor Circulating Anodic Antigen (CAA). METHODS: We applied Bayesian latent class analyses (LCA), first considering CCA traces as negative and then as positive. We used the LCA output to estimate validity of the prevalence estimates of each test in comparison to the population-level infection prevalence and estimated the proportion of trace results that were likely true positives. RESULTS: Kato-Katz yielded the lowest prevalence (6.8%), and CCAB with trace considered positive yielded the highest (53.5%). There were many more trace results recorded by CCA in Burundi (32.4%) than in Leiden (2.3%). Estimated prevalence with CAA was 46.5%. LCA indicated that Kato-Katz had the lowest sensitivity: 15.9% [Bayesian Credible Interval (BCI): 9.2–23.5%] with CCA-trace considered negative and 15.0% with trace as positive (BCI: 9.6–21.4%), implying that Kato-Katz missed approximately 85% of infections. CCAB underestimated disease prevalence when trace was considered negative and overestimated disease prevalence when trace was considered positive, by approximately 12 percentage points each way, and CAA overestimated prevalence in both models. Our results suggest that approximately 52.2% (BCI: 37.8–5.8%) of the CCAB trace readings were true infections. CONCLUSIONS: Whether measured in the laboratory or the field, CCA outperformed Kato-Katz at the low infection intensities in Burundi. CCA with trace as negative likely missed many infections, whereas CCA with trace as positive overestimated prevalence. In the absence of a field-friendly gold standard diagnostic, the use of a variety of diagnostics with differing properties will become increasingly important as programs move towards elimination of schistosomiasis. It is clear that CCA is a valuable tool for the detection and mapping of S. mansoni infection in the field and CAA may be a valuable field tool in the future. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-018-2700-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-23 /pmc/articles/PMC5824563/ /pubmed/29475457 http://dx.doi.org/10.1186/s13071-018-2700-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Clements, Michelle N.
Corstjens, Paul L. A. M.
Binder, Sue
Campbell, Carl H.
de Dood, Claudia J.
Fenwick, Alan
Harrison, Wendy
Kayugi, Donatien
King, Charles H.
Kornelis, Dieuwke
Ndayishimiye, Onesime
Ortu, Giuseppina
Lamine, Mariama Sani
Zivieri, Antonio
Colley, Daniel G.
van Dam, Govert J.
Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi
title Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi
title_full Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi
title_fullStr Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi
title_full_unstemmed Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi
title_short Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi
title_sort latent class analysis to evaluate performance of point-of-care cca for low-intensity schistosoma mansoni infections in burundi
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824563/
https://www.ncbi.nlm.nih.gov/pubmed/29475457
http://dx.doi.org/10.1186/s13071-018-2700-4
work_keys_str_mv AT clementsmichellen latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT corstjenspaullam latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT bindersue latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT campbellcarlh latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT dedoodclaudiaj latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT fenwickalan latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT harrisonwendy latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT kayugidonatien latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT kingcharlesh latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT kornelisdieuwke latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT ndayishimiyeonesime latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT ortugiuseppina latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT laminemariamasani latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT zivieriantonio latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT colleydanielg latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi
AT vandamgovertj latentclassanalysistoevaluateperformanceofpointofcareccaforlowintensityschistosomamansoniinfectionsinburundi